• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

Dolores “Dee” Holden Norris (1946–2025), Ted’s wife, championed the award and the standards of clinical excellence it represents. In December 2025, the International Alliance paid tribute to Dee — nurse, advocate, co-founder of the Alliance, and a driving force behind the multidisciplinary model of ALS/MND care.

Working alongside Ted, she helped transform how ALS/MND care is delivered worldwide. At a time when patients were often offered little more than prognosis, they envisioned something fundamentally different: coordinated, team-based care grounded in clinical excellence and compassion. Their work helped establish the global standard for multidisciplinary ALS/MND clinics and laid the foundation for the collaborative international community that exists today.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period will open on July 1. 

Primary Sidebar

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Jean Waters, UK

    Jean Waters, UK

  • Bayley, Australia

    Bayley, Australia

  • Phil Rossall, UK

    Phil Rossall, UK

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Philip Brindle, England

    Philip Brindle, England

  • Anita Forte, USA

    Anita Forte, USA

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Paul Launer, USA

    Paul Launer, USA

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Lee Millard, England

    Lee Millard, England

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Purningam Jacob, India

    Purningam Jacob, India

  • Jack Buzby, USA

    Jack Buzby, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Anna Barrow, UK

    Anna Barrow, UK

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Steve

    Steve

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Ali Var, Turkey

    Ali Var, Turkey

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Animesh Kumar, India

    Animesh Kumar, India

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • David Solomon, UK

    David Solomon, UK

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login